Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

MDT

Medtronic (MDT)

Medtronic PLC
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:MDT
일자시간출처헤드라인심볼기업
2024/05/3006:10PR Newswire (US)Medtronic announces pricing of €3.0 billion of senior notesNYSE:MDTMedtronic PLC
2024/05/3006:10PR Newswire (Canada)Medtronic announces pricing of €3.0 billion of senior notesNYSE:MDTMedtronic PLC
2024/05/3005:12Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:MDTMedtronic PLC
2024/05/2405:17Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:MDTMedtronic PLC
2024/05/2320:35IH Market NewsU.S. Futures Rise, Oil Prices ClimbNYSE:MDTMedtronic PLC
2024/05/2319:47Edgar (US Regulatory)Form 8-K - Current reportNYSE:MDTMedtronic PLC
2024/05/2319:45PR Newswire (US)Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increaseNYSE:MDTMedtronic PLC
2024/05/2319:45PR Newswire (Canada)Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increaseNYSE:MDTMedtronic PLC
2024/05/2023:54PR Newswire (Canada)MiniMed™ 780G system recognized among Fast Company's 2024 World Changing IdeasNYSE:MDTMedtronic PLC
2024/05/2023:54PR Newswire (US)MiniMed™ 780G system recognized among Fast Company's 2024 World Changing IdeasNYSE:MDTMedtronic PLC
2024/05/2021:31PR Newswire (US)EuroPCR: Medtronic Evolut™ TAVR Platform Demonstrates Improved Quality of Life for Women with Severe Aortic StenosisNYSE:MDTMedtronic PLC
2024/05/1805:31PR Newswire (Canada)Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatmentNYSE:MDTMedtronic PLC
2024/05/1805:31PR Newswire (US)Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatmentNYSE:MDTMedtronic PLC
2024/05/1800:35PR Newswire (Canada)Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™NYSE:MDTMedtronic PLC
2024/05/1800:35PR Newswire (US)Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™NYSE:MDTMedtronic PLC
2024/05/0921:45PR Newswire (Canada)Medtronic to announce financial results for its fourth quarter and full fiscal year 2024NYSE:MDTMedtronic PLC
2024/05/0921:45PR Newswire (US)Medtronic to announce financial results for its fourth quarter and full fiscal year 2024NYSE:MDTMedtronic PLC
2024/04/2620:56PR Newswire (US)Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulatorNYSE:MDTMedtronic PLC
2024/04/2620:56PR Newswire (Canada)Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulatorNYSE:MDTMedtronic PLC
2024/04/1720:02PR Newswire (US)Americans favor quality over quantity in pursuit of longevityNYSE:MDTMedtronic PLC
2024/04/1720:02PR Newswire (Canada)Americans favor quality over quantity in pursuit of longevityNYSE:MDTMedtronic PLC
2024/04/1021:30PR Newswire (Canada)Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic careNYSE:MDTMedtronic PLC
2024/04/1021:30PR Newswire (US)Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic careNYSE:MDTMedtronic PLC
2024/04/0821:00PR Newswire (Canada)The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillationNYSE:MDTMedtronic PLC
2024/04/0821:00PR Newswire (US)The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillationNYSE:MDTMedtronic PLC
2024/04/0722:45PR Newswire (Canada)SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily womenNYSE:MDTMedtronic PLC
2024/04/0722:45PR Newswire (US)SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily womenNYSE:MDTMedtronic PLC
2024/04/0721:00PR Newswire (Canada)New survey uncovers lack of awareness around heart valve disease and risk factors among womenNYSE:MDTMedtronic PLC
2024/04/0721:00PR Newswire (US)New survey uncovers lack of awareness around heart valve disease and risk factors among womenNYSE:MDTMedtronic PLC
2024/03/2721:00PR Newswire (Canada)Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosisNYSE:MDTMedtronic PLC
 검색 관련기사 보기:NYSE:MDT

최근 히스토리

Delayed Upgrade Clock